FibroGen's Grant

FibroGen raised a round of funding on July 24, 2003. Investors include National Cancer Institute.

FibroGen is a biotechnology company focused on the discovery, development, and commercialization of therapeutic agents for treatment of anemia, fibrosis, cancer, and other serious unmet medical needs.…

Articles about FibroGen's Grant: